Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke

[1] Miyakis S(2006)International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295-306

[2] Lockshin MD(2018)Diagnosis and management of the antiphospholipid syndrome N Engl J Med 378 2010-2021

[3] Atsumi T(2020)The antiphospholipid syndrome: often overlooked cause of vascular occlusions? J Intern Med 287 349-372

[4] Branch DW(2002)Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients Arthritis Rheum 46 1019-1027

[5] Brey RL(2008)Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons Curr Rheumatol Rep 10 67-73

[6] Cervera R(2009)Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study Lancet Neurol 8 998-1005

[7] DerksenDeg RHPG(2017)Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls Immunol Res 65 470-476

[8] Koike T(2004)Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke JAMA 291 576-584

[9] Meroni PL(2001)beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program Stroke 32 1701-1706

[10] Reber G(2015)Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome Autoimmunity 48 275-281

[1] Miyakis S(2006)International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295-306

[2] Lockshin MD(2018)Diagnosis and management of the antiphospholipid syndrome N Engl J Med 378 2010-2021

[3] Atsumi T(2020)The antiphospholipid syndrome: often overlooked cause of vascular occlusions? J Intern Med 287 349-372

[4] Branch DW(2002)Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients Arthritis Rheum 46 1019-1027

[5] Brey RL(2008)Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons Curr Rheumatol Rep 10 67-73

[6] Cervera R(2009)Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study Lancet Neurol 8 998-1005

[7] DerksenDeg RHPG(2017)Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls Immunol Res 65 470-476

[8] Koike T(2004)Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke JAMA 291 576-584

[9] Meroni PL(2001)beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program Stroke 32 1701-1706

[10] Reber G(2015)Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome Autoimmunity 48 275-281